DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Plicamycin
Plicamycin
Combination of Cabazitaxel and Plicamycin Induces Cell Death in Drug Resistant B-Cell Acute Lymphoblastic Leukemia
PEMD-91-12BR Off-Label Drugs: Initial Results of a National Survey
Drug Code List Version 11.4 Revised 5/18/18 List Will Be Updated Routinely
Pharmaceutical Appendix to the Tariff Schedule 2
Identification of Inhibitors of Ovarian Cancer Stem-Like Cells by High-Throughput Screening Roman Mezencev, Lijuan Wang and John F Mcdonald*
Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients with Breast Cancer: Estimates from SEER-Medicare Data
Multistage Delivery of Active Agents
Innovative Design of Early Phase Clinical Trials in Radiation Oncology
Testimony of Manon Ress on Behalf of the Union for Affordable Cancer Treatment (UACT)
Healthy U Medical Pharmacy Prior Authorization List
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients
WO 2012/136553 Al 11 October 2012 (11.10.2012) P O P C T
(12) Patent Application Publication (10) Pub. No.: US 2003/0198664 A1 Sullivan Et Al
Cancer Drug Costs for a Month of Treatment at Initial Food
Stembook 2018.Pdf
About Ewing Tumors What Is the Ewing Family of Tumors?
Top View
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
Molecular and Cellular Mechanisms of Human Astrocytoma Progression: Advances in Knowledge to Reach Therapeutic Horizons
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Disease Site-Delivering Pharmaceutical Compositions Comprising Paclitaxel
Large-Scale Drug Screening in Patient-Derived IDH Glioma Stem
2019 Table of Drugs
OF Publication Classification DISEASES INVOLVING CELL (51) Int
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
MANUAL for Medical Facilities
Bacille Calmette-Guérin (BCG)
Chemical Protocol Review
Supplementary Information for Drug Metabolism and Disposition
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Patient Drug Locker Procedures
INJECTABLE CHEMOTHERAPY DRUGS: APPLICATION of NCCN CLINICAL PRACTICE GUIDELINES Policy Number: CANCER 009.18 T2 Effective Date: June 1, 2018
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug Administration Approval
NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
Symptom Management Myelosuppression Grading
An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Guide to Extravasation Management in Adult & Pediatric Patients
Supplementary Online Content
Hazardous Drug List
Medications That Are Considered Hazardous
(12) United States Patent (10) Patent No.: US 6,702,850 B1 Byun Et Al
Antineoplastic Drugs